Louisville, KY, United States of America

Shelia Diann Thomas


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Shelia Diann Thomas

Introduction

Shelia Diann Thomas is a prominent inventor based in Louisville, KY (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on compositions and methods that aim to inhibit cell proliferation and induce cell death in cancer cells.

Latest Patents

Thomas's latest patents include groundbreaking compositions and methods for treating cancer. One of her notable inventions involves quadruplex-forming guanine-rich nucleic acid sequences that are useful in inhibiting cellular growth and proliferation. These compositions are designed to provide a safe and effective amount of a sequence with at least 80% nucleic acid identity with specific sequences, along with a carrier that allows the isolated oligonucleotide to form at least one quadruplex. This innovative approach holds promise for enhancing cancer treatment efficacy.

Career Highlights

Shelia Diann Thomas is affiliated with the University of Louisville Research Foundation, Inc., where she continues to advance her research in cancer therapies. Her dedication to innovation in this critical field has positioned her as a key figure in the development of new treatment methodologies.

Collaborations

Throughout her career, Thomas has collaborated with esteemed colleagues, including Donald Miller and Kara Joyce Sedoris. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.

Conclusion

Shelia Diann Thomas exemplifies the spirit of innovation in the medical field, particularly in cancer research. Her contributions through patented inventions are paving the way for new therapeutic strategies that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…